We are live on ! Find out more
QC

Quantessence Capital Portfolio holdings

AUM $20.5M
1-Year Est. Return 71.02%
This Fund
S&P 500
This Quarter Est. Return
+14.43%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$60.2M
Cap. Flow
-$87.3M
Cap. Flow %
-25.71%
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302

Top Buys

Rank Stock Value
1
AZEK
The AZEK Co
AZEK
+$58.6M
2
RDFN
Redfin
RDFN
+$35.6M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.53M
4
SFM icon
Sprouts Farmers Market
SFM
+$7.45M
5
INSM icon
Insmed
INSM
+$5.79M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$30.3M
2
XLC icon
State Street Communication Services Select Sector SPDR ETF
XLC
+$12.3M
3
XOM icon
ExxonMobil
XOM
+$11.3M
4
BECN
Beacon Roofing Supply, Inc.
BECN
+$10.8M
5
PFE icon
Pfizer
PFE
+$10.6M

Sector Composition

Rank Sector Weight
1 Industrials 31.47%
2 Real Estate 13.23%
3 Healthcare 10.04%
4 Financials 9.26%
5 Consumer Discretionary 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLT icon
301
Hilton Worldwide
HLT
$74.3B
– –
-4,482
Closed -$1.02M
HLX icon
302
Helix Energy Solutions
HLX
$1.46B
– –
-18,200
Closed -$151K
HMY icon
303
Harmony Gold Mining
HMY
$10B
– –
-21,300
Closed -$315K
HNI icon
304
HNI Corp
HNI
$3.01B
– –
-6,400
Closed -$284K
HOOD icon
305
Robinhood
HOOD
$85.6B
– –
-25,047
Closed -$1.04M
HRB icon
306
H&R Block
HRB
$5.18B
– –
-16,700
Closed -$917K
IBM icon
307
IBM
IBM
$203B
– –
-1,650
Closed -$410K
IBP icon
308
Installed Building Products
IBP
$6.14B
– –
-1,300
Closed -$223K
IKT icon
309
Inhibikase Therapeutics
IKT
$388M
– –
-13,005
Closed -$28.5K
INDV icon
310
Indivior Pharmaceuticals
INDV
$4.78B
– –
-84,812
Closed -$808K
INTR icon
311
Inter&Co
INTR
$2.42B
– –
-136,560
Closed -$748K
IOT icon
312
Samsara
IOT
$19B
– –
-25,995
Closed -$996K
IRWD icon
313
Ironwood Pharmaceuticals
IRWD
$624M
– –
-58,149
Closed -$85.5K
JOBY icon
314
Joby Aviation
JOBY
$7.03B
– –
-171,848
Closed -$1.03M
JPM icon
315
JPMorgan Chase
JPM
$937B
– –
-5,425
Closed -$1.33M
JXN icon
316
Jackson Financial
JXN
$8.28B
– –
-11,630
Closed -$974K
KBH icon
317
KB Home
KBH
$3.49B
– –
-4,800
Closed -$279K
KLAC icon
318
KLA
KLAC
$283B
– –
-37,070
Closed -$2.52M
KMB icon
319
Kimberly-Clark
KMB
$36.2B
– –
-8,400
Closed -$1.19M
KNF icon
320
Knife River
KNF
$4.48B
– –
-9,295
Closed -$839K
KO icon
321
Coca-Cola
KO
$353B
– –
-55,300
Closed -$3.96M
KOPN icon
322
Kopin
KOPN
$676M
– –
-81,804
Closed -$76.3K
KRMD icon
323
KORU Medical Systems
KRMD
$175M
– –
-16,469
Closed -$41.8K
KTB icon
324
Kontoor Brands
KTB
$4.68B
– –
-5,700
Closed -$366K
KVUE icon
325
Kenvue
KVUE
$36.8B
– –
-43,100
Closed -$1.03M
11 12
13
14 15

Similar funds

FS
Financially Speaking Greenwood Village, Colorado $20.6M AUM 24.93% 1-Year Est. Return
BC
Bakala Capital Greenville, South Carolina $20.8M AUM 13.01% 1-Year Est. Return
LFA
LGT Financial Advisors Dallas, Texas $19.5M AUM 22.6% 1-Year Est. Return
HAM
Honeycomb Asset Management New York $19.4M AUM 25.86% 1-Year Est. Return
DP
Declaration Partners New York $21.8M AUM
SPC
Stone Point Capital Greenwich, Connecticut $21.9M AUM 47.18% 1-Year Est. Return
IW
Imprint Wealth Mount Pleasant, South Carolina $21.9M AUM
SRHG
Stone Ridge Holdings Group New York $19M AUM 8.85% 1-Year Est. Return

Quantessence Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Quantessence Capital held 483 positions worth $340M, down 15% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Quantessence Capital withdrew a net $87.3M in Q2 2025, closing 302 positions and reducing 18 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 11% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Quantessence Capital opened a new position in The AZEK Co worth $63.6M.

  • Quantessence Capital's largest Q2 2025 buy was The AZEK Co: 1,170,131 shares worth $63.6M.
  • Quantessence Capital added most to Merck in Q2 2025, an estimated $3.19M increase.
  • Quantessence Capital's biggest Q2 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $1.84M.
  • Quantessence Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $30.3M.
  • Quantessence Capital's ten largest holdings make up 46% of its $340M portfolio in Q2 2025.
  • Quantessence Capital opened 151 new positions and closed 302 in Q2 2025.
  • Quantessence Capital's portfolio value fell 15% quarter-over-quarter to $340M.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.